طراحی وب سایت

the council for responsible nutrition, one of the dietary supplement industry\'s leading trade associations, in consultation with independent osteoporosis and vitamin a experts, responded to the results of a new study on hip fractures from the nurses\' health study (nhs) data by reaffirming that the current upper limits (ul) for vitamin a set by the institute of medicine (iom) provide an appropriate safeguard for the general population.

nearly 62 million americans have some form of cardiovascular disease, and nearly a million die from it each year, statistics published on monday show. heart disease is by far the no. 1 killer in the united states, although a third of those deaths could be prevented if people ate better diets and exercised more, the american heart association said in it annual report on heart statistics. it said 61.

bangladeshi agro-based company fine foods limited (ffl) has launched an initial public offering (ipo) to raise 32 million taka ($561,403), company officials said on wednesday. ffl will offer 1.5 million shares at 10 taka each starting on january 7 and closing the following day, the officials said. the company has already raised 17 million taka by issuing 1.7 million shares to institutional investors in pre-ipo placements.

russia\'s leading dairy products and fruit juices company is set to launch an initial public offering on the new york stock exchange in the next few weeks. wimm bill dann, which sells j7 brand of juices, as well as milk, yoghurt and other products, is set to offer 25-30 per cent of its expanded share capital via a listing of american depositary receipts. the company, which is privately held by a small group of executives, is believed to be preparing to offer its shares in late january, with the deal being closed shortly afterwards.

a group of advisors to the us food and drug administration (fda) will meet on january 24 to provide recommendations to the agency about possible new labeling for wyeth-ayerst\'s rapamune oral solution and tablets. rapamune is already approved for prevention of organ rejection in renal transplant patients. the current us labeling states that the drug is to be used in a regimen with cyclosporine and corticosteroids, the fda said in announcing the meeting.

conagra foods\' recent move to separate financial results of its branded foods from agricultural businesses might be more than a bookkeeping shuffle, and could prepare the ground for an eventual spinoff or sale of the company\'s slower-growing units, analysts said. \"this could be the first step,\" said deutsche banc alex. brown analyst eric katzman. \"they\'ve been putting resources behind the higher-margin packaged foods areas, and by their own admission have disclosed that parts of their agricultural products, and even meat-processing, have underperformed.

french dairy giant group danone is reviving its plans for india. it has now proposed to convert its proposed 80 per cent subsidiary into a 100 per cent company, and capitalise it to rs 150 crore over five years instead of the original plan for rs 306 crore. however, during the first phase, the company will make an initial investment of only around rs 14.5 crore. when the company first showed an interest in the indian market in 1996, it had proposed to make an equity investment of rs 245 crore.

fast food chain burger king announced yesterday it was to create 1,250 jobs next year. burger king, owned by drinks giant diageo, will generate the full and part time positions by opening 35 restaurants, bringing the total number of uk outlets up to 720. the move is part of a long-term plan to open 300 burger king restaurants over the next five years, creating a total of 11,000 jobs in the process.

shares of imclone systems inc. fell nearly 16 percent on monday after regulators said they would not accept the biotechnology company\'s application to sell its eagerly awaited colon cancer drug, erbitux. while the company\'s chief executive, sam waksal, told investors he doesn\'t believe imclone will need to conduct new trials to get approval, analysts said the likely delay in launching the drug is a blow.